Status | Study |
Completed |
Study Name: Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? Condition: Oral Mucositis Effects of Chemotherapy Malignant Date: 2013-12-19 Interventions: Device: Low level laser therapy Low level laser therapy: Laser Therapy XT (DMC) having red light with a |
Completed |
Study Name: Velcade Consolidation Bone Study Condition: Multiple Myeloma Date: 2011-01-27 Interventions: Drug: bortezomib Each cycle will consist of 5 weeks treatment. Subjects in the treatment group will rece |
Completed |
Study Name: Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD Condition: Multiple Myeloma Date: 2009-05-21 Interventions: Drug: Cyclophosphamide 500 mg, |
Completed |
Study Name: The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) Condition: Multiple Myeloma Date: 2007-02-15 Interventions: Drug: bortezomib |
Terminated |
Study Name: A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma Condition: Multiple Myeloma Date: 2007-02-02 Interventions: Drug: PXD101 |
Completed |
Study Name: Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers Condition: Hematologic Neoplasms Bone Marrow Neoplasms Date: 2007-01-10 Interventions: Drug: Darinaparsin 300mg/m2 of Darinaparsin given daily for five consecutive days to be repeated every 2 |
Recruiting |
Study Name: Effect of Chemotherapy Administered Before Surgery on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells Condition: Breast Neoplasms Date: 2006-07-17 Interventions: Procedure: Peripheral blood draw Procedure |
Completed |
Study Name: SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. Condition: Bone Marrow Diseases Myelodysplastic Syndromes Hematologic Date: 2005-06-10 Interventions: Drug: SCIO-469 SCIO-469 tablet |